1. Global Initiative for Asthma. Global strategy for asthma management and prevention. https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf (2020). Accessed 12 June 2020.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 report. https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.1wms.pdf (2020). Accessed 12 June 2020.
3. Allan R, Haughie S, Ahrens R, et al. A dose-response study examining the use of methacholine challenge to demonstrate local therapeutic equivalence of the salmeterol component of generic inhaled fluticasone propionate/salmeterol combination products. J Aerosol Med Pulm Drug Deliv. 2019;32:352–63.
4. Mylan announces FDA approval of Wixela™ Inhub™ (fluticasone propionate and salmeterol inhalation powder, USP), first generic of Advair Diskus® (fluticasone propionate and salmeterol inhalation powder. Hertfordshire, England and Pittsburgh, PA. 31 Jan 2019.
5. Advair Diskus prices, coupons and patient assistance programs. Updated November 2, 2020. https://www.drugs.com/price-guide/advair-diskus. Accessed 11 Nov 2020.